Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy
Authors (first, second and last of 13)

The Journal of Hematopathology provides pathologists interested in hematopathology with information needed to perform high-quality diagnostic pathology of hematopoietic and lymphoid disease in lymphoid tissues, bone marrow and peripheral blood. The Journal publishes reviews, editorials, comments, original papers, guidelines and protocols, papers on ancillary techniques, case reports, and images on all topics within the subspecialty of diagnostic hematopathology.
The Journal maintains an international character, helping to address the considerable geographical variations in incidence of diseases.
The Journal offers a useful reference point for all pathologists with an interest in hematopathology. Molecular biologists involved in the expanding field of molecular diagnostics and research on lymphomas and leukemia, benefit from the journal too. Furthermore, the journal is of major interest for hematologists dealing with patients suffering from lymphomas, leukemias, and other benign and malignant hematopoietic and lymphoid diseases.
This journal follows a double-blind reviewing procedure. Submitted manuscripts will be reviewed by experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. Reviewers will also be asked to indicate how interesting and significant the research is. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board. Where an Editor is a co-author or has any other competing interest regarding a specific manuscript, they will not participate in the peer-review process and the article will be assigned by the Publisher to a member of the Editorial Board.
Please see the Submission Guidelines for more information on article requirements and submitting to the journal.
The Journal of Hematopathology is delighted to invite you to submit your papers to be part of its new collection. Click through for more information and submit today. We look forward to reading your work.
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Avoid the most common mistakes and prepare your manuscript for journal editors.
Learn more